🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationBacteriostatic water sourcing and sterility considerations

Bacteriostatic water sourcing and sterility considerations

SarahChen_PharmD Sun, Jun 7, 2026 at 5:41 PM 8 replies 114 viewsPage 1 of 2
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Jun 7, 2026 at 5:41 PM#1

A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about the dosing arithmetic, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Do it in two steps and it stops being confusing. First concentration: 10mg into 2ml is 5mg/ml. Then volume: a 0.5mg dose is 0.5 ÷ 5 = 0.1ml. Then units, and this is where people go wrong — a U-100 syringe is graduated in hundredths of a millilitre, so 0.1ml is 10 units. The word "units" has nothing to do with milligrams; it is a volume marking that exists because insulin happens to come at 100 units per ml.

The condition it depends on

The arithmetic is right and one caveat matters: a U-40 syringe changes the markings, not the volumes. If someone hands you U-40 and you read it as U-100 you will be 2.5 times out, and that error has a direction — it is always an overdose.

The practical version

The three numbers to write on the vial: total mg, total ml, and mg per ml. Everything else is division. And the sanity check is that dose volume times number of doses should be less than the volume you put in, because dead space takes the difference.

What I am not sure about

The bit I cannot resolve on my own is how to check the arithmetic without trusting a website calculator, since three calculators gave me three answers. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

— SarahChen_PharmD · corrections welcome and will be edited into this post with credit
10 5Dr.ObesityLA, NurseKim_ATL, paul_denver and 7 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Jun 7, 2026 at 5:49 PM#2
SarahChen_PharmD said:
Do it in two steps and it stops being confusing.

That is correct as far as it goes, and here is where it stops going. Concentration choice is a precision decision, not a preference. Reconstitute high and every dose is a tiny volume where one unit of syringe error is a large fraction of the dose. Reconstitute low and you get more graduations per dose, so the same hand tremor costs proportionally less. Against that, more diluent means more benzyl alcohol and a shorter comfortable in-use window.

9 4Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 6 others
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Jun 7, 2026 at 5:57 PM#3
SarahChen_PharmD said:
Do it in two steps and it stops being confusing.

I am going to disagree with reconstituting low as a general rule. More diluent, more punctures, more in-use days at room temperature, and the stability trade-off is real. Precision is not the only variable being optimised.

Last edited: Jun 7, 2026 at 8:57 PM
8 3Admin, Dr.Martinez, mike_mod and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jun 7, 2026 at 6:05 PM#4

Taking the question as asked, rather than the general version of it. Dead space is the answer to the missing dose. A fixed-needle insulin syringe holds a few microlitres in the hub and needle after the plunger bottoms out, and on small draws that is a measurable percentage of every dose. Across ten draws it adds up to most of an eleventh, which is exactly the "nine draws from a ten-dose vial" complaint. Luer-lock syringes are worse; low-dead-space fixed-needle designs are better.

7 2SaraMom3, Dr.MetabolicMD, RetaRick_CA and 4 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Jun 7, 2026 at 6:45 PM#5
KevinCompounds said:
Concentration choice is a precision decision, not a preference.

Right, and one flattering data point from a group buy is not consistency. Consistency means separate batches, separately commissioned, over months.

Correct me if the detail matters more than I have assumed.

Last edited: Jun 7, 2026 at 8:45 PM
6 1gary_naperville, sean_dublin, hannah_MT and 3 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
Beyond-use dating for compounded peptides — USP <797> compliance6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register